StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Benchmark Reiterates Buy Rating on IMAX Corporation (IMAX), Highlights 'The Odyssey' Potential
June 26, 2026 9:29 AM
Benchmark analyst Mike Hickey reiterated a Buy rating and $60.00 price target on IMAX Corporation (NYSE: IMAX).The analyst commented, "Our ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments